Secondary Non-Responder to Tumor Necrosis Factor Inhibitor Successfully Responds to Baricitinib Treatment: A Case Report

INTRODUCTION Rheumatoid Arthritis (RA) is a systemic autoimmune disease that is characterized by inflammatory arthritis of the joints and extra-articular manifestations. According to the World Health Organization, the prevalence of RA varies between 0.3% and 1%. The disease is more commonly seen in women than in men.1 Though the etiology Read more…